Ontogeny of malate-aspartate shuttle capacity and gene expression in cardiac mitochondria

The American Journal of Physiology
T D ScholzB C Schutte

Abstract

Developmental downregulation of the malate-aspartate shuttle has been observed in cardiac mitochondria. The goals of this study were to determine the time course of the postnatal decline and to identify potential regulatory sites by measuring steady-state myocardial mRNA and protein levels of the mitochondrial proteins involved in the shuttle. By use of isolated porcine cardiac mitochondria incubated with saturating concentrations of the cytosolic components of the malate-aspartate shuttle, shuttle capacity was found to decline by approximately 50% during the first 5 wk of life (from 921 +/- 48 to 531 +/- 53 nmol.min-1.mg protein-1). Mitochondrial aspartate aminotransferase mRNA levels were greater in adult than in newborn myocardium. mRNA levels of mitochondrial malate dehydrogenase in adult cardiac tissue were 224% of levels in newborn tissue, whereas protein levels were 54% greater in adult myocardium. Aspartate/glutamate carrier protein levels were also greater in adult than in newborn tissue. mRNA and protein levels of the oxoglutarate/malate carrier were increased in newborn myocardium. It was concluded that 1) myocardial malate-aspartate shuttle capacity declines rapidly after birth, 2) divergence of mitochondrial malate...Continue Reading

References

Oct 1, 1975·Archives of Biochemistry and Biophysics·R J Tomec, C L Hoppel
Dec 1, 1992·Cardiovascular Research·G D LopaschukT Itoi
Jan 1, 1992·DNA Sequence : the Journal of DNA Sequencing and Mapping·V IacobazziJ E Walker
Oct 15, 1991·Biochemical and Biophysical Research Communications·K Y YehP R Holt
Jun 1, 1990·The American Journal of Medicine·W H Dillmann
Sep 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·T JohY Morino
Apr 1, 1985·Physiological Reviews·C T Jones, T P Rolph
Feb 1, 1971·Metabolism: Clinical and Experimental·K F LaNoue, J R Williamson
Jun 1, 1971·Journal of Molecular and Cellular Cardiology·B SaferJ R Williamson
Mar 19, 1981·The New England Journal of Medicine·D A Fisher, A H Klein
May 1, 1981·Pediatric Research·D J FisherA M Rudolph
Mar 16, 1995·Brain Research. Developmental Brain Research·Y Mhaskar, G A Dunaway
Sep 29, 1994·The New England Journal of Medicine·G A Brent
Jan 1, 1993·Critical Reviews in Biochemistry and Molecular Biology·J Kuan, M H Saier
Jan 1, 1997·BioTechniques·B C SchutteN Dracopoli
Jun 1, 1997·Journal of Molecular and Cellular Cardiology·T D ScholzB C Schutte

❮ Previous
Next ❯

Citations

Nov 28, 2001·The Journal of Biological Chemistry·Brian D FinkWilliam I Sivitz
Dec 8, 2004·Journal of the Society for Gynecologic Investigation·Timothy L van NattaJeffrey L Segar
Nov 27, 2008·Clinical Science·Nicholas H von BergenThomas D Scholz
Jun 2, 2016·Scientific Reports·Heng ZhangHongfang Jin
Nov 18, 2000·American Journal of Physiology. Cell Physiology·J L GriffinE D Lewandowski
Dec 18, 2001·Journal of Neuroscience Research·K F LaNoueS Hutson
Feb 4, 2003·The Journal of Biological Chemistry·Edwin JanssenBé Wieringa
Mar 15, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Gregory B DalshaugJeffrey L Segar
Sep 2, 2004·American Journal of Physiology. Endocrinology and Metabolism·Brian D FinkWilliam I Sivitz
Jan 24, 2007·Physiological Reviews·Jorgina SatrústeguiAraceli Del Arco
Mar 6, 2010·Annals of the New York Academy of Sciences·Heinrich TaegtmeyerDeborah Vela
Oct 11, 2016·Oxidative Medicine and Cellular Longevity·Jia LiuJunbao Du
Nov 14, 2001·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·J L SegarT D Scholz
May 23, 2007·Heart Failure Reviews·Mitra RajabiHeinrich Taegtmeyer
Oct 14, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Aaron K OlsonMichael A Portman
Jul 31, 2008·Acta Pharmacologica Sinica·Shu-xu DuJun-bao Du
Dec 24, 2004·American Journal of Physiology. Heart and Circulatory Physiology·J Carter RalpheThomas D Scholz
Feb 18, 2017·The Journal of Pharmacology and Experimental Therapeutics·Enrique ChávezVictoria Chagoya de Sánchez
Feb 1, 2000·Journal of Molecular and Cellular Cardiology·T D ScholzB C Schutte
Dec 13, 2000·Journal of Molecular and Cellular Cardiology·B E RupertT D Scholz
Aug 2, 2003·Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology·H S LeongM F Allard
Nov 27, 2004·Journal of Cellular Biochemistry·Agnes Shuk-Yee LoMary Miu-Yee Waye
Aug 8, 2006·Biochemical and Biophysical Research Communications·Lin Eng NgKim Ping Wong
Jul 8, 2008·Journal of Theoretical Biology·Ming LuXin Yu
Oct 25, 2011·Biochemical and Biophysical Research Communications·Liman LuoJunbao Du

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.